Pituitary hormone level changes and hyponatremia in aneurysmal subarachnoid hemorrhage

Experimental and Therapeutic Medicine

Volumn 5, Issue 6, 2013, Pages 1657-1662

  Maimaitili, Aisha ^a   Maimaitili, Mijiti ^a   Rexidan, Aikeremu ^a   Lu, Junyi ^a   Ajimu, Kuerban ^a   Cheng, Xiaojiang ^a   Luo, Kun ^a   Sailike, Duishanbai ^a   Liu, Yuan ^a   Kaheerman, Kadeer ^a   Tang, Changjiu ^a   Zhang, Tingrong ^a  

^a XINJIANG MEDICAL UNIVERSITY   (China)

Author keywords

Aneurysm; Hyponatremia; Pituitary hormone; Subarachnoid hemorrhage

Indexed keywords

CORTICOTROPIN; ELECTROLYTE; FOLLITROPIN; GROWTH HORMONE; HYPOPHYSIS HORMONE; LUTEINIZING HORMONE; PROLACTIN; SODIUM; THYROTROPIN;

ADULT; AGED; ANTERIOR CEREBRAL ARTERY; ANTERIOR COMMUNICATING ARTERY; ARTICLE; BRAIN VASOSPASM; CLINICAL ARTICLE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; HUMAN; HYPONATREMIA; MALE; MORBIDITY; POSTERIOR COMMUNICATING ARTERY; SUBARACHNOID HEMORRHAGE;

EID: 84876553399     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2013.1068     Document Type: Article

References (24)

1. Teasdale GM, Wardlaw JM, White PM, Murray G, et al: The familial risk of subarachnoid haemorrhage. Brain 128: 1677-1685, 2005.
2. Sherlock M, O'Sullivan E, Agha A, et al: The incidence and pathophysiology of hyponatraemia after subarachnoid haemorrhage. Clin Endocrinol (Oxf) 64: 250-254, 2006.
3. Katayama Y, Haraoka J, Hirabayashi H, et al: A randomized controlled trial of hydrocortisone against hyponatremia in patients with aneurysmal subarachnoid hemorrhage. Stroke 38: 2373-2375, 2007.
4. Rahman M and Friedman WA: Hyponatremia in neurosurgical patients: clinical guidelines development. Neurosurgery 65: 925-935, 2009.
5. Hunt WE and Hess RM: Surgical risks as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg 28: 14-20, 1968.
6. Zervas NT and Ogilvy CS: Cerebral vasospasm: current clinical management and results. Clin Neurosurg 45: 167-176, 1999.
7. Wang ZG, Ji Y and Ding X: Dynamical changes of the serum concentration of pituitary hormone in patients with aneurysmal subarachnoid hemorrhage. J Shandong Univ (Health Science) 44: 1241-1244, 2006 (In Chinese).
8. Zhou F, Qiu JB and Guo JQ: Clinical research on cerebrospinal fluid concentration of pituitary hormone in patients with aneurysmal subarachnoid hemorrhage. J Clin Surg 13: 168-170, 2005 (In Chinese).
9. He CM and Gu YJ: Significance of level of thyroid hormone in coma patients due to acute cerebral vascular disease. China Trop Med 8: 2027-2028, 2008 (In Chinese).
10. Dorai Z, Hynan LS, Kopitnik TA and Samson D: Factors related to hydrocephalus after aneurysmal subarachnoid hemorrhage. Neurosurgery 52: 763-769, 2003.
11. Turowski B, du Mesnil de Rochemont R, Beck J, Berkefeld J and Zanella FE: Assessment of changes in cerebral circulation time due to vasospasm in a specific arterial territory: effect of angioplasty. Neuroradiology 47: 134-143, 2005.
12. Fraser JF and Stieg PE: Hyponatremia in the neurosurgical patient: epidemiology, pathophysiology, diagnosis and management. Neurosurgery 59: 222-229, 2006.
13. Tsutsumi S, Yasumoto Y and Ito M: Central pontine and extrapontine myelinolysis in an infant associated with the treatment of craniopharyngioma: case report. Neurol Med Chir (Tokyo) 48: 351-354, 2008.
14. Kawahara I, Tokunaga Y, Ishizaka S and Yagi N: Reversible clinical and magnetic resonance imaging of central pontine myelinolysis following surgery for craniopharyngioma: serial magnetic resonance imaging studies. Neurol Med Chir (Tokyo) 49: 120-123, 2009.
15. Harrigan MR: Cerebral salt wasting syndrome: a review. Neurosurgery 38: 152-160, 1996.
16. Kurokawa Y, Uede T, Ishiguro M, Honda O, Honmou O, Kato T and Wanibuchi M: Pathogenesis of hyponatremia following subarachnoid hemorrhage due to ruptured cerebral aneurysm. Surg Neurol 46: 500-507, 1996.
17. Ogawasara K, Kinouchi H, Nagamine Y, Koshu K and Fujiwara S: Differential diagnosis of hyponatremia following subarachnoid hemorrhage. No Shinkei Geka 26: 501-505, 1998 (In Japanese).
18. Cardoso AP, Dragosavac D, Araújo S, et al: Syndromes related to sodium and arginine vasopressin alterations in postoperative neurosurgery. Arq Neuropsiquiatr 65: 745-751, 2007.
19. Scherle-Matamoros E, Perez-Nellar J and Castro-Jimenez M: Clinical usefulness of transcranial Doppler ultrasound imaging in the diagnosis of cerebral vasospasm in subarachnoid hemorrhage. A validation study. Rev Neurol 47: 295-298, 2008 (In Spanish).
20. Webb A, Kolenda J, Martin K, Wright W and Samuels O: The effect of intraventricular administration of nicardipine on mean cerebral blood flow velocity measured by transcranial Doppler in the treatment of vasospasm following aneurysmal subarachnoid hemorrhage. Neurocrit Care 12: 159-164, 2010.
21. Dupont SA, Wijdicks EF, Manno EM, Lanzino G and Rabinstein AA: Prediction of angiographic vasospasm after aneurysmal subarachnoid hemorrhage: value of the Hijdran sum scoring system. Neurocritical Care 11: 172-176, 2009.
22. Shi XF, Zhang QJ and Hu YH: Pathogenesis of symptomatic cerebrovascular spasm due to aneurysmal subarachnoid hemorrhage. Chin J Clin Neurosurg 8: 338-340, 2003.
23. Winn RH (ed): Youmans Neurological Surgery. 5th edition. Saunders, Philadelphia, PA, 2004
24. Dorhout Mees SM, Rinkel GJ, Feigin VL, et al: Calcium antagonists for aneurysmal subarachnoid hemorrhage. Cochrane Database Syst Rev 3: CD000277, 2007.